4//SEC Filing
Smith Brigitte 4
Accession 0001181431-13-006520
CIK 0001293310other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:12 PM ET
Size
9.1 KB
Accession
0001181431-13-006520
Insider Transaction Report
Form 4
Smith Brigitte
Director
Transactions
- Purchase
Common Stock
2013-01-31$8.00/sh+25,000$200,000→ 25,000 total(indirect: By GBS Bioventures II A/C)
Footnotes (1)
- [F1]Represents securities held directly by GBS Bioventures II A/C ("Bioventures"). The Reporting Person is a managing director of GBS Venture Partners Pty Ltd which manages Bioventures. The Reporting Person shares voting and investment power with another partner and may be deemed to be an indirect beneficial owner of the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Issuer
KALOBIOS PHARMACEUTICALS INC
CIK 0001293310
Entity typeother
Related Parties
1- filerCIK 0001555775
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:12 PM ET
- Size
- 9.1 KB